Differential characterization using readily accessible NMR experiments of novel N- and O-alkylated quinolin-4-ol, 1,5-naphthyridin-4-ol and quinazolin-4-ol derivatives with antimycobacterial activity

During the construction of bioactive molecules, regioselective alkylation of heterocyclic, N/O ambident nucleophiles is a frequently encountered synthetic transformation. In this framework, specific attention is required to unambiguously determine the structures of obtained reaction products. As par...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of medicinal chemistry 2017-01, Vol.125, p.890-901
Hauptverfasser: Pitta, Eleni, Balabon, Olga, Rogacki, Maciej K., Gómez, Jesús, Cunningham, Fraser, Joosens, Jurgen, Augustyns, Koen, van der Veken, Pieter, Bates, Robert
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 901
container_issue
container_start_page 890
container_title European journal of medicinal chemistry
container_volume 125
creator Pitta, Eleni
Balabon, Olga
Rogacki, Maciej K.
Gómez, Jesús
Cunningham, Fraser
Joosens, Jurgen
Augustyns, Koen
van der Veken, Pieter
Bates, Robert
description During the construction of bioactive molecules, regioselective alkylation of heterocyclic, N/O ambident nucleophiles is a frequently encountered synthetic transformation. In this framework, specific attention is required to unambiguously determine the structures of obtained reaction products. As part of our project on quinoloxyacetamide based antimycobacterial agents, a series of N- or O- alkylated quinolin-4-ol, 1,5-naphthyridin-4-ol and quinazolin-4-ol derivatives were prepared during the course of which we observed unexpected selectivity issues. After finding that no consistent procedure existed in the literature for assigning regioisomers of this type, we applied three readily accessible NMR experiment types (13C NMR, HSQC/HMBC and NOE) to resolve any uncertainties regarding the obtained regioisomeric structures. Furthermore, the antimycobacterial activity of all final compounds was evaluated with the best compound 23 showing potent antitubercular activity (MIC = 1.25 μM) without cytotoxic effects. [Display omitted] •Azaheterocyclic analogues of quinoloxyacetamide antimycobacterials are reported.•Potent antimycobacterial scaffolds were identified.•Unambiguous structure determination was carried out by 13C-NMR, HSQC/HMBC and NOE.•NMR methodology can be applied generally for ambident heterocyclic nucleophiles.
doi_str_mv 10.1016/j.ejmech.2016.10.014
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1835526441</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0223523416308765</els_id><sourcerecordid>1835526441</sourcerecordid><originalsourceid>FETCH-LOGICAL-c408t-a1c7c221d39af26ddcff29e597403debc571a4b8b4daf04b0c546e57ae642fe23</originalsourceid><addsrcrecordid>eNp9kc2OFCEUhYnROO3oGxjD0sXQAkVVdW9MzPibjDOJ0TWh4GLTUkUPUKU1L-hrSVvtLF0BJ9-5PxyEnjO6ZpQ1r_Zr2Pegd2teXkVaUyYeoBVrmw2peC0eohXlvCI1r8QZepLSnlJaN5Q-Rme8bZstregK_X7rrIUIQ3bKY71TUekM0d2p7MKAx-SG7ziCMs7PWGkNKbnOA77-_AXDr0Mh--JNOFg8hAk8viZYDQbfEOV_zF5lMPh2dEPwbiCCBH-B2UVNBnXY5d0cnTnJf01HUN3do9iU8lMZZIKEf7q8K1B2_axDtwxZJi4XN7k8P0WPrPIJnp3Oc_Tt_buvlx_J1c2HT5dvrogWdJOJYrrVnDNTbZXljTHaWr6FetsKWhnodN0yJbpNJ4yyVHRU16KBulXQCG6BV-fo5VL3EMPtCCnL3iUN3qsBwpgk21R1zRshWEHFguoYUopg5aH8loqzZFQeI5R7uUQojxEe1RJhsb04dRi7Hsy96V9mBXi9AFD2nBxEmbSDQYNxEXSWJrj_d_gDr_Kzrw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1835526441</pqid></control><display><type>article</type><title>Differential characterization using readily accessible NMR experiments of novel N- and O-alkylated quinolin-4-ol, 1,5-naphthyridin-4-ol and quinazolin-4-ol derivatives with antimycobacterial activity</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Pitta, Eleni ; Balabon, Olga ; Rogacki, Maciej K. ; Gómez, Jesús ; Cunningham, Fraser ; Joosens, Jurgen ; Augustyns, Koen ; van der Veken, Pieter ; Bates, Robert</creator><creatorcontrib>Pitta, Eleni ; Balabon, Olga ; Rogacki, Maciej K. ; Gómez, Jesús ; Cunningham, Fraser ; Joosens, Jurgen ; Augustyns, Koen ; van der Veken, Pieter ; Bates, Robert</creatorcontrib><description>During the construction of bioactive molecules, regioselective alkylation of heterocyclic, N/O ambident nucleophiles is a frequently encountered synthetic transformation. In this framework, specific attention is required to unambiguously determine the structures of obtained reaction products. As part of our project on quinoloxyacetamide based antimycobacterial agents, a series of N- or O- alkylated quinolin-4-ol, 1,5-naphthyridin-4-ol and quinazolin-4-ol derivatives were prepared during the course of which we observed unexpected selectivity issues. After finding that no consistent procedure existed in the literature for assigning regioisomers of this type, we applied three readily accessible NMR experiment types (13C NMR, HSQC/HMBC and NOE) to resolve any uncertainties regarding the obtained regioisomeric structures. Furthermore, the antimycobacterial activity of all final compounds was evaluated with the best compound 23 showing potent antitubercular activity (MIC = 1.25 μM) without cytotoxic effects. [Display omitted] •Azaheterocyclic analogues of quinoloxyacetamide antimycobacterials are reported.•Potent antimycobacterial scaffolds were identified.•Unambiguous structure determination was carried out by 13C-NMR, HSQC/HMBC and NOE.•NMR methodology can be applied generally for ambident heterocyclic nucleophiles.</description><identifier>ISSN: 0223-5234</identifier><identifier>EISSN: 1768-3254</identifier><identifier>DOI: 10.1016/j.ejmech.2016.10.014</identifier><identifier>PMID: 27769030</identifier><language>eng</language><publisher>France: Elsevier Masson SAS</publisher><subject>Alkylation ; Anti-Bacterial Agents - chemistry ; Anti-Bacterial Agents - pharmacology ; Antitubercular Agents - chemistry ; Cell Survival - drug effects ; Magnetic Resonance Spectroscopy - methods ; Molecular Structure ; Mycobacteriaceae - drug effects ; Naphthyridines - chemistry ; Naphthyridines - pharmacology ; Naphthyridinol ; NMR ; Quinazolines - chemistry ; Quinazolines - pharmacology ; Quinazolinol ; Quinolinol ; Regioselectivity ; Tuberculosis</subject><ispartof>European journal of medicinal chemistry, 2017-01, Vol.125, p.890-901</ispartof><rights>2016 Elsevier Masson SAS</rights><rights>Copyright © 2016 Elsevier Masson SAS. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c408t-a1c7c221d39af26ddcff29e597403debc571a4b8b4daf04b0c546e57ae642fe23</citedby><cites>FETCH-LOGICAL-c408t-a1c7c221d39af26ddcff29e597403debc571a4b8b4daf04b0c546e57ae642fe23</cites><orcidid>0000-0002-2590-8678 ; 0000-0001-5981-8438</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ejmech.2016.10.014$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,777,781,3537,27905,27906,45976</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27769030$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pitta, Eleni</creatorcontrib><creatorcontrib>Balabon, Olga</creatorcontrib><creatorcontrib>Rogacki, Maciej K.</creatorcontrib><creatorcontrib>Gómez, Jesús</creatorcontrib><creatorcontrib>Cunningham, Fraser</creatorcontrib><creatorcontrib>Joosens, Jurgen</creatorcontrib><creatorcontrib>Augustyns, Koen</creatorcontrib><creatorcontrib>van der Veken, Pieter</creatorcontrib><creatorcontrib>Bates, Robert</creatorcontrib><title>Differential characterization using readily accessible NMR experiments of novel N- and O-alkylated quinolin-4-ol, 1,5-naphthyridin-4-ol and quinazolin-4-ol derivatives with antimycobacterial activity</title><title>European journal of medicinal chemistry</title><addtitle>Eur J Med Chem</addtitle><description>During the construction of bioactive molecules, regioselective alkylation of heterocyclic, N/O ambident nucleophiles is a frequently encountered synthetic transformation. In this framework, specific attention is required to unambiguously determine the structures of obtained reaction products. As part of our project on quinoloxyacetamide based antimycobacterial agents, a series of N- or O- alkylated quinolin-4-ol, 1,5-naphthyridin-4-ol and quinazolin-4-ol derivatives were prepared during the course of which we observed unexpected selectivity issues. After finding that no consistent procedure existed in the literature for assigning regioisomers of this type, we applied three readily accessible NMR experiment types (13C NMR, HSQC/HMBC and NOE) to resolve any uncertainties regarding the obtained regioisomeric structures. Furthermore, the antimycobacterial activity of all final compounds was evaluated with the best compound 23 showing potent antitubercular activity (MIC = 1.25 μM) without cytotoxic effects. [Display omitted] •Azaheterocyclic analogues of quinoloxyacetamide antimycobacterials are reported.•Potent antimycobacterial scaffolds were identified.•Unambiguous structure determination was carried out by 13C-NMR, HSQC/HMBC and NOE.•NMR methodology can be applied generally for ambident heterocyclic nucleophiles.</description><subject>Alkylation</subject><subject>Anti-Bacterial Agents - chemistry</subject><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Antitubercular Agents - chemistry</subject><subject>Cell Survival - drug effects</subject><subject>Magnetic Resonance Spectroscopy - methods</subject><subject>Molecular Structure</subject><subject>Mycobacteriaceae - drug effects</subject><subject>Naphthyridines - chemistry</subject><subject>Naphthyridines - pharmacology</subject><subject>Naphthyridinol</subject><subject>NMR</subject><subject>Quinazolines - chemistry</subject><subject>Quinazolines - pharmacology</subject><subject>Quinazolinol</subject><subject>Quinolinol</subject><subject>Regioselectivity</subject><subject>Tuberculosis</subject><issn>0223-5234</issn><issn>1768-3254</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kc2OFCEUhYnROO3oGxjD0sXQAkVVdW9MzPibjDOJ0TWh4GLTUkUPUKU1L-hrSVvtLF0BJ9-5PxyEnjO6ZpQ1r_Zr2Pegd2teXkVaUyYeoBVrmw2peC0eohXlvCI1r8QZepLSnlJaN5Q-Rme8bZstregK_X7rrIUIQ3bKY71TUekM0d2p7MKAx-SG7ziCMs7PWGkNKbnOA77-_AXDr0Mh--JNOFg8hAk8viZYDQbfEOV_zF5lMPh2dEPwbiCCBH-B2UVNBnXY5d0cnTnJf01HUN3do9iU8lMZZIKEf7q8K1B2_axDtwxZJi4XN7k8P0WPrPIJnp3Oc_Tt_buvlx_J1c2HT5dvrogWdJOJYrrVnDNTbZXljTHaWr6FetsKWhnodN0yJbpNJ4yyVHRU16KBulXQCG6BV-fo5VL3EMPtCCnL3iUN3qsBwpgk21R1zRshWEHFguoYUopg5aH8loqzZFQeI5R7uUQojxEe1RJhsb04dRi7Hsy96V9mBXi9AFD2nBxEmbSDQYNxEXSWJrj_d_gDr_Kzrw</recordid><startdate>20170105</startdate><enddate>20170105</enddate><creator>Pitta, Eleni</creator><creator>Balabon, Olga</creator><creator>Rogacki, Maciej K.</creator><creator>Gómez, Jesús</creator><creator>Cunningham, Fraser</creator><creator>Joosens, Jurgen</creator><creator>Augustyns, Koen</creator><creator>van der Veken, Pieter</creator><creator>Bates, Robert</creator><general>Elsevier Masson SAS</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-2590-8678</orcidid><orcidid>https://orcid.org/0000-0001-5981-8438</orcidid></search><sort><creationdate>20170105</creationdate><title>Differential characterization using readily accessible NMR experiments of novel N- and O-alkylated quinolin-4-ol, 1,5-naphthyridin-4-ol and quinazolin-4-ol derivatives with antimycobacterial activity</title><author>Pitta, Eleni ; Balabon, Olga ; Rogacki, Maciej K. ; Gómez, Jesús ; Cunningham, Fraser ; Joosens, Jurgen ; Augustyns, Koen ; van der Veken, Pieter ; Bates, Robert</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c408t-a1c7c221d39af26ddcff29e597403debc571a4b8b4daf04b0c546e57ae642fe23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Alkylation</topic><topic>Anti-Bacterial Agents - chemistry</topic><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Antitubercular Agents - chemistry</topic><topic>Cell Survival - drug effects</topic><topic>Magnetic Resonance Spectroscopy - methods</topic><topic>Molecular Structure</topic><topic>Mycobacteriaceae - drug effects</topic><topic>Naphthyridines - chemistry</topic><topic>Naphthyridines - pharmacology</topic><topic>Naphthyridinol</topic><topic>NMR</topic><topic>Quinazolines - chemistry</topic><topic>Quinazolines - pharmacology</topic><topic>Quinazolinol</topic><topic>Quinolinol</topic><topic>Regioselectivity</topic><topic>Tuberculosis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pitta, Eleni</creatorcontrib><creatorcontrib>Balabon, Olga</creatorcontrib><creatorcontrib>Rogacki, Maciej K.</creatorcontrib><creatorcontrib>Gómez, Jesús</creatorcontrib><creatorcontrib>Cunningham, Fraser</creatorcontrib><creatorcontrib>Joosens, Jurgen</creatorcontrib><creatorcontrib>Augustyns, Koen</creatorcontrib><creatorcontrib>van der Veken, Pieter</creatorcontrib><creatorcontrib>Bates, Robert</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pitta, Eleni</au><au>Balabon, Olga</au><au>Rogacki, Maciej K.</au><au>Gómez, Jesús</au><au>Cunningham, Fraser</au><au>Joosens, Jurgen</au><au>Augustyns, Koen</au><au>van der Veken, Pieter</au><au>Bates, Robert</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Differential characterization using readily accessible NMR experiments of novel N- and O-alkylated quinolin-4-ol, 1,5-naphthyridin-4-ol and quinazolin-4-ol derivatives with antimycobacterial activity</atitle><jtitle>European journal of medicinal chemistry</jtitle><addtitle>Eur J Med Chem</addtitle><date>2017-01-05</date><risdate>2017</risdate><volume>125</volume><spage>890</spage><epage>901</epage><pages>890-901</pages><issn>0223-5234</issn><eissn>1768-3254</eissn><abstract>During the construction of bioactive molecules, regioselective alkylation of heterocyclic, N/O ambident nucleophiles is a frequently encountered synthetic transformation. In this framework, specific attention is required to unambiguously determine the structures of obtained reaction products. As part of our project on quinoloxyacetamide based antimycobacterial agents, a series of N- or O- alkylated quinolin-4-ol, 1,5-naphthyridin-4-ol and quinazolin-4-ol derivatives were prepared during the course of which we observed unexpected selectivity issues. After finding that no consistent procedure existed in the literature for assigning regioisomers of this type, we applied three readily accessible NMR experiment types (13C NMR, HSQC/HMBC and NOE) to resolve any uncertainties regarding the obtained regioisomeric structures. Furthermore, the antimycobacterial activity of all final compounds was evaluated with the best compound 23 showing potent antitubercular activity (MIC = 1.25 μM) without cytotoxic effects. [Display omitted] •Azaheterocyclic analogues of quinoloxyacetamide antimycobacterials are reported.•Potent antimycobacterial scaffolds were identified.•Unambiguous structure determination was carried out by 13C-NMR, HSQC/HMBC and NOE.•NMR methodology can be applied generally for ambident heterocyclic nucleophiles.</abstract><cop>France</cop><pub>Elsevier Masson SAS</pub><pmid>27769030</pmid><doi>10.1016/j.ejmech.2016.10.014</doi><tpages>12</tpages><orcidid>https://orcid.org/0000-0002-2590-8678</orcidid><orcidid>https://orcid.org/0000-0001-5981-8438</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0223-5234
ispartof European journal of medicinal chemistry, 2017-01, Vol.125, p.890-901
issn 0223-5234
1768-3254
language eng
recordid cdi_proquest_miscellaneous_1835526441
source MEDLINE; Elsevier ScienceDirect Journals
subjects Alkylation
Anti-Bacterial Agents - chemistry
Anti-Bacterial Agents - pharmacology
Antitubercular Agents - chemistry
Cell Survival - drug effects
Magnetic Resonance Spectroscopy - methods
Molecular Structure
Mycobacteriaceae - drug effects
Naphthyridines - chemistry
Naphthyridines - pharmacology
Naphthyridinol
NMR
Quinazolines - chemistry
Quinazolines - pharmacology
Quinazolinol
Quinolinol
Regioselectivity
Tuberculosis
title Differential characterization using readily accessible NMR experiments of novel N- and O-alkylated quinolin-4-ol, 1,5-naphthyridin-4-ol and quinazolin-4-ol derivatives with antimycobacterial activity
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T22%3A09%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Differential%20characterization%20using%20readily%20accessible%20NMR%20experiments%20of%20novel%20N-%20and%20O-alkylated%20quinolin-4-ol,%201,5-naphthyridin-4-ol%20and%20quinazolin-4-ol%20derivatives%20with%20antimycobacterial%20activity&rft.jtitle=European%20journal%20of%20medicinal%20chemistry&rft.au=Pitta,%20Eleni&rft.date=2017-01-05&rft.volume=125&rft.spage=890&rft.epage=901&rft.pages=890-901&rft.issn=0223-5234&rft.eissn=1768-3254&rft_id=info:doi/10.1016/j.ejmech.2016.10.014&rft_dat=%3Cproquest_cross%3E1835526441%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1835526441&rft_id=info:pmid/27769030&rft_els_id=S0223523416308765&rfr_iscdi=true